Seongnam, South Korea

Ock-Youm Jeon

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2010-2011.


% Patents Active = 66.7


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ock-Youm Jeon: Innovator in Molecular Transporters

Introduction

Ock-Youm Jeon is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of molecular transporters, particularly those based on sugar and its analogues. With a total of 3 patents, his work focuses on enhancing the delivery of biologically active molecules through biological membranes.

Latest Patents

One of his latest patents involves molecular transporters that demonstrate significantly high permeability through various biological membranes, including the plasma membrane, nuclear membrane, and blood-brain barrier. This innovative molecular transporter compound can effectively deliver a range of biologically active molecules, showcasing its potential in medical applications.

Career Highlights

Ock-Youm Jeon has worked with reputable organizations such as the Postech Foundation and the Postech Academy-Industry Foundation. His experience in these institutions has allowed him to advance his research and development in the field of molecular transporters.

Collaborations

Throughout his career, Ock-Youm Jeon has collaborated with esteemed colleagues, including Sung-Kee Chung and Kaustabh Kumar Maiti. These partnerships have contributed to the success of his innovative projects.

Conclusion

Ock-Youm Jeon is a prominent figure in the development of molecular transporters, with a focus on enhancing the delivery of biologically active molecules. His contributions to this field are significant and continue to impact medical research and applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…